Staphylococcus aureus is the major organism responsible for surgical implant infections. 49
Staphylococcus aureus is a gram-positive pathogen associated with a variety of disease 83 processes from self-limited abscesses to life-threatening sepsis. These episodes are typically 84 acute, and resolve over a limited time-period with either minimal or high morbidity and mortality 85
(1). An exception includes S. aureus related surgical infection, especially those associated with 86 medical devices. Surgical site infection is one of the most common health-care associated 87
infections (2). Unlike the majority of S. aureus infections, these infections can be chronic, 88
indolent, and challenging to treat. 89 90
Periprosthetic joint infection illustrates this challenge. Total knee arthroplasty is a common 91 surgical procedure, and the most common reason for failure is infection, termed periprosthetic 92 joint infection (3, 4) . S. aureus periprosthetic joint infection can be culture negative for 93 prolonged periods (5, 6) , has high failure rates above 50% once treatment is initiated (5), and a 94
5-year mortality of 20% (7-9), higher than many common cancers (10). Similar to other surgical 95 implant associated infections, the challenge in treating this disease involves the ability of S. 96
aureus to develop a chronic biofilm associated infection tolerant to antibiotics (11, 12) . 97 98
In gram-positive bacteria, the mechanisms behind biofilm antibiotic tolerance and the ability to 99 form chronic infections are poorly understood. It is suspected that toxin-antitoxin systems play 100 an important role in these processes. Toxin-antitoxin (TA) systems encode a stable toxin 101
protein capable of interfering with vital cellular processes and a labile antitoxin that counteracts 102 the toxin (13) (14) (15) . In S. aureus, the most well studied of these is the mazEF module where 103 mazF is a stable toxin that cleaves specific mRNA, and mazE is an unstable antitoxin that 104 inhibits mazF (16). In gram negative and acid-fast species, this system has been associated 105
with antibiotic tolerance (17) and virulence (18). In S. aureus, the mazEF phenotype is 106 controversial and its physiologic function in the disease process is unknown 107 108
The objective of this study was to identify a phenotype associated with mazEF in the S. aureus 109 disease process. We hypothesized that toxin-antitoxin systems like mazEF contribute to the 110 ability to establish chronic infections and antibiotic tolerant biofilms. Disruption of mazF 111 expression in three different S. aureus strains, resulted in increased biofilm formation and a 112 loss of antibiotic tolerance as compared to their wild-type strains on surgical implant material. 113
In planktonic culture, when mazF disruption did alter growth, this was associated with antibiotic 114
tolerance. In our animal model, the absence of mazF resulted in a more acute, pathogenic 115
infection that was more difficult to treat with antibiotics. These phenotypes demonstrated that 116 mazF expression resulted in lower growth and metabolic activity from decreased biofilm 117 formation that allowed a transition from an acute to chronic biofilm infection and increased 118 antibiotic tolerance. 119 120
Results 121 122
Disruption of mazF is associated with increased biofilm formation on surgical implant 123 material 124
Toxin antitoxin systems are associated with bacteria growth arrest (19) (20) (21) . We hypothesized 125 that the lack of mazF would result in increased biofilm formation from preventing growth 126 inhibition. Mature S. aureus (USA300 JE2) biofilm was cultured on titanium rods and 127 quantitative culture was performed to asses biofilm mass. Disruption of mazF had increased 128 biofilm mass as compared to parental strains ( Fig. 1 ). We observed similar results on two 129 additional methicillin sensitive S. aureus (MSSA) strains deleted for mazF, Newman (22) and 130 SH1000 (23) (Fig. S1 ).These experiments were repeated, and biofilm was cultured on 131 polystyrene, and quantified with crystal violet assay. A loss of mazF expression again resulted 132 in increased biofilm mass on fibrinogen-coated wells in all three strains as compared to wild 133 type ( Fig. S2) . To confirm the observed phenotype of mazF in S. aureus, we restored mazF 134 expression in trans and observed a decrease in biofilm formation (Fig. S3 ).
136
Loss of mazF expression decreases biofilm antibiotic tolerance 137
In gram negative bacteria, mazEF contributes to antibiotic tolerance and bacterial persisters 138
(24-26). The role of mazEF and other toxin-antitoxin systems in S. aureus antibiotic tolerance 139
is conflicting and unclear (27, 28) . We hypothesized that mazEF would contribute to biofilm 140 antibiotic tolerance in S. aureus. Biofilm antibiotic tolerance was compared between the 141 methicillin resistant S. aureus (MRSA) strain JE2 and its corresponding strain disrupted for the 142 mazF gene. Mature biofilm cultured on surgical implant material was exposed to 10x minimum 143 inhibitory concentration (MIC) of vancomycin, and quantitative culture was used to assess 144 remaining biofilm mass over three days. Loss of mazF expression had a statistically significant 145
increased loss of biofilm mass as compared to the wild type control demonstrating that loss of 146 mazF expression decreased biofilm antibiotic tolerance (Fig. 2) . These results were confirmed 147 in two additional strains, Newman and SH1000, using both cefazolin and vancomycin (Fig. 148 S4). For all three strains, there was no statistical difference in MICs between the wild type and 149 loss of function strains for cefazolin or vancomycin (Supplemental Table 1 ). 150 151
Lack of mazF expression only altered planktonic antibiotic tolerance when doubling rate 152 was altered 153
After observing these strong mazF biofilm phenotypes of increased biofilm formation and 154 decreased antibiotic tolerance, we questioned if a similar pattern would be observed in 155 planktonic culture. The growth rate of these three S. aureus strains were compared after 156 exiting stationary phase. Loss of mazF expression resulted in a statistically significant 157 increased early logarithmic planktonic growth rate in JE2 and SH1000 S. aureus strains, but 158 this was not observed at each time point. When the early logarithmic doubling time was 159 compared, only SH1000 and JE2 had a statistically increased doubling rate ( Fig. 3A ) and 160
Newman did not. A similar pattern was observed with planktonic antibiotic tolerance; deletion 161 or disruption of mazF only decreased antibiotic tolerance in the same strains that had an 162 increase in doubling rate, JE2 and SH1000 (Figs. 3B, 3C).
164
Loss of mazF expression did not alter sigB transcription 165
The sigB operon is a master regulator in S. aureus that allows it to rapidly redirect 166 transcriptional activities in response to stress (22) . It has the potential to be a major regulator 167 of S. aureus biofilm formation and virulence (29). The sigB operon is directly downstream from 168 mazEF, and disruption of mazF expression could possibly alter sigB expression. We looked at 169 sigB expression and genes upstream and downstream of mazF to verify that neighboring gene 170 expression was not altered. Quantitative RT-PCR analysis demonstrated no change in 171 expression of sigB and the sigB dependent gene, asp23 (alkaline shock protein 23), between 172 the three strains with loss of mazF expression and their respective wild type control ( Fig. 4A  173 and B). We also examined the expression of the genes rpoF, rsbW, and alr which are directly 174 upstream and downstream of mazF, based on genomic location and transcriptional order, 175
using qRT-PCR. There was no statistically significant difference in rpoF, rsbW and alr 176 expression between these strains and their wild type control ( Fig. S5 ). These results 177 demonstrate that loss of mazF did not alter expression of neighboring genes. The observed 178
phenotype was related to the loss of mazF and not changes in sigB operon or other 179 neighboring gene expression. 180 181
Disruption of mazF increased pathogenicity, limited the ability of S. aureus to transition 182 from an acute to chronic infection, and inhibited antibiotic tolerance 183
If lack of mazF expression increased biofilm formation, we hypothesized that this increased 184 proliferation would result in increased disease severity. To test this hypothesis, we used a 185 murine abscess model. After inoculation in the hind limb, quantitative culture was used to 186 determine abscess bacterial burden at increasing time points in wild type and the mazF::tn 187 strain. We selected the strain JE2 for these experiments as it was the most clinically relevant 188 strain. In immune competent mice, loss of mazF had a similar phenotype to in vitro 189 observations with increased proliferation and biofilm mass as compared to the wild type strain.
190
After one week, the infection was on a downward trajectory after day 3 ( Fig. 5A ). To increase 191 disease severity, we repeated experiments in neutropenic mice. Loss of mazF expression had 192 increased proliferation and burden as compared to wild-type bacteria. Further, we observed a 193 more virulent and aggressive infection. Wild type mice had almost 100% survival whereas 194 mice inoculated with the mazF disrupted strain developed sepsis and death with survival at 195 25% by day 7 (Fig. 5B) . Surprisingly, although a more aggressive infection was observed, the 196 mazF disrupted strain was more sensitive to antibiotics than the wild type control. After 197
inoculation, there was a larger decrease in bacterial burden after treatment with vancomycin in 198 the mazF::tn strain as compared to the wild type ( Fig. 5C ). Together these results supported 199
the two in vitro phenotypes we observed, and suggest that mazF contributes to a phenotype of 200 decreased virulence and pathogenesis. 201 202
Increased biofilm formation in a mazF-disrupted strain is ica-dependent 203
After a phenotype for mazF and a possible role in pathogenesis was identified, we attempted 204
to identify a mechanism behind its regulatory control. The intercellular adhesion gene cluster 205 (ica) is composed of icaA, icaD, icaB and icaC, and encodes proteins that promotes 206 intercellular adhesion in many strains and species of Staphylococcus (30). Deletion of mazF in 207 S. aureus results in increased biofilm formation that is ica-dependent (31). To test the 208 hypotheses that the phenotype of increased growth and pathogenesis from loss of mazF 209 expression was ica-dependent, we deleted the icaADBC genes from the mazF::tn strain to 210 generate a mazF::tn/ΔicaADBC strain. S. aureus mazF::tn/ΔicaADBC strains had lower biofilm 211 formation than the wild type and mazF::tn strains (Fig. 6A ). The neutropenic murine abscess 212 model was repeated with the mazF::tn/ΔicaADBC strain. The phenotype associated with loss 213 of mazF expression was again suppressed. Mice inoculated with the mazF::tn/ΔicaADBC had 214 comparable survival to the wild type control whereas the mazF::tn strain had 50% survival ( Fig.  215 6C). The mazF::tn/ΔicaADBC strain overcorrected the mazF::tn growth phenotype confirming 216 the roles of icaA, icaB, icaC and icaD in mazEF function and suggests that these 4 genes are 217
likely involved in controlling other process outside the mazEF system. The ability of the 218 mazF::tn/ΔicaADBC strain to restore survival in the murine abscess model confirmed a role of 219 ica control of biofilm formation in pathogenesis. 220
221
Decreased biofilm antibiotic tolerance in a mazF disruption is not ica-dependent 222 We then tested the role of icaADBC in regulating mazF biofilm antibiotic tolerance. Mature 223 biofilm was exposed to 10x MIC vancomycin. mazF::tn and mazF::tn/ΔicaADBC strains had 224 decreased vancomycin tolerance compared with wild type strain. Unlike the biofilm formation 225 phenotype where deletion of icaADBC reversed the mazF disruption phenotype, loss of both 226 mazF and icaADBC expression resulted in even less biofilm antibiotic tolerance than loss of 227 mazF alone. This demonstrated that ica genes were also involved in antibiotic tolerance as 228 well (Fig. 6B ).
230
Discussion 231 232
The physiologic role of bacterial toxin-antitoxin systems remain unknown. In S. aureus, mazEF 233
is a well-studied toxin-antitoxin system whose phenotype and physiologic role in S. aureus 234 remains elusive. Loss of mazF expression resulted in a phenotype of increased biofilm 235 formation on surgical implant material and decreased biofilm antibiotic tolerance in all three S. 236
aureus strains, but little change in planktonic cells. In our murine abscess model, the 237 phenotypes associated with mazEF contributed to a biofilm-dependent disease process that is 238 consistent with most chronic bacterial infections and the clinical manifestation of surgical 239
infections. Further mechanistic analysis supported a role for extracellular polysaccharide 240
adhesins in the increased biofilm formation and pathogenesis when mazF expression is 241 disrupted. Combined, these results suggest that mazEF helps regulate the transition between 242
acute to chronic infection in S. aureus. 243 244
Regulation of growth and biofilm formation is a phenotype associated with TA systems. The 245 mechanism of toxin-antitoxin systems includes an antitoxin that prevents the toxin from 246
inducing growth arrest using a variety of tools (24, 32) . After loss of mazF expression, we 247
observed increased biofilm when compared to its isogenic wild-type strain on fibrinogen-coated 248 plastic and titanium in vitro and in vivo. This supports the work of other groups where 249 overexpression of mazF in S. aureus resulted in growth arrest (21) and mazF mutants had 250 increased biofilm formation (31). This is the primary mechanism where bacteria are thought to 251 become antibiotic tolerant from toxin-antitoxin systems; dormant bacteria are tolerant to an 252 antibiotic whose main process is disrupting their metabolism. 253 254
There is evidence to suggest that TA systems play an important role in antibiotic tolerance 255 based on multiple examples in gram negative species (26) as well as in acid-fast 256
mycobacterium (17). Although there is less evidence for this phenotype in gram-positive 257 organisms, it has been suspected a similar pattern exists in S. aureus. We observed a 258 difference in biofilm antibiotic tolerance when mazF expression was disrupted as compared to 259 its wild type strains (Fig. 2 Persisters are a subpopulation of bacteria that have a phenotypic tolerance to antibiotics (33, 267 34). The mechanism behind this tolerance is thought to be regulated by the metabolic state of 268 the cell (35) . We observed that the role of mazF in antibiotic tolerance appears to be correlated 269 with growth. The phenotype of antibiotic tolerance was more weakly observed in planktonic S. 270
aureus strains (Fig. 3) . In planktonic culture, only loss of function strains with decreased 271 doubling times as compared to the wild type strains were observed to have decreased 272 planktonic antibiotic tolerance. This supports other results suggesting that persister formation 273
is based on ATP levels, and is an area of future work. Likely, multiple mechanisms exist to 274 support persister cell formation and antibiotic tolerance, including the stringent response (28).
276
Biofilm formation is an important step for S. aureus to establish an infection. This is regulated 277 by polysaccharide intercellular adhesin (PIA/PNAG) encoded by the ica operon (36). Based on 278
this and our observation that loss of mazF expression increased biofilm formation, we 279 speculated that mazF inhibits biofilm formation by decreasing ica transcription. A 280 mazF::tn/ΔicaADBC strain reversed the in vitro and in vivo phenotypes from loss of mazF 281 expression ( Fig. 6 ). This mazF::tn ΔicaADBC strain had similar pathogenicity as the wild type 282
strain. This provides evidence that ica-mediated biofilm formation and pathogenicity are 283
inhibited by mazF. This supports other groups observations that S. aureus biofilm formation is 284 dependent on mazF mRNA interferase activity (31). 285 286
S. aureus infections are typically acute. Although there is a range of pathogenesis from simple, 287 superficial abscesses to life threatening systemic sepsis, the outcomes of these disease 288 processes resolve over a limited time period. An exception is surgical infection where chronic 289
infections can develop over an extended period of time and biofilm formation plays an 290 important physiologic role (5, 11). Regulation of growth, biofilm formation, and antibiotic 291 tolerance could have important roles of bacteria physiology in this disease state. S. aureus 292 biofilm formation is an essential step in establishing infection and pathogenicity (37, 38).
293
Surprisingly, although loss of mazF created a more virulent organism with higher lethality, 294
these infections were also more susceptible to antibiotics. Combined, these results suggest 295
that mazF expression inhibits biofilm formation and increases antibiotic tolerance allowing the 296 bacteria to transition to a chronic infection that is more challenging to treat. This demonstrates 297 a physiologic role for toxin antitoxin systems during infections. MazEF toxin antitoxin systems 298 not only make the bacteria more tolerant to antibiotics but makes the bacteria more tolerant to 299 the host. 300 301
Materials and Methods 302 303
Bacterial strains, plasmids and growth conditions 304
USA 300 JE2 was selected as the primary strain as it was the most clinically relevant, and 305 USA300 clones have the highest growth rate as compared to other common S. aureus strains 306
(39). All bacterial strains and plasmids used in this study are listed in The transformed mazF expression vector was transformed into the mazF::tn strain and 326 selected with 200 μg/ml spectinomycin. 327 328
Isolation of RNA and quantitative RT-PCR analysis 329
RNA isolation and quantitative reverse transcription polymerase chain reaction (RT-PCR) were 330 performed by following the manufacturer's instruction of the product. In brief, S. aureus was 331 grown in 4 mL of TSB medium supplemented with appropriate antibiotics at 37°C for 16 hours. 332
Overnight culture was centrifuged, and pellet resuspended in TE Buffer by vortexing. 500 333 μg/ml lysostaphin (Sigma-Aldrich) was added to the resuspended bacteria and incubate at 334 37°C for 15 minutes. Total RNA was extracted using TRIzol® Max™ Bacterial RNA Isolation 335
Kit (Thermo Fisher Scientific). Single-stranded cDNA was created from reverse transcription of 336 the RNA using SuperScript IV Reverse Transcriptase (Thermo Fisher Scientific). The newly 337
synthesized cDNA was used immediately or frozen at -80 C. 338
Quantitative RT-PCR analysis was performed using the CFX96 Real-Time System (BioRad, 339 Richmond, CA) and PowerUp TM SYBR Green Master Mix (Thermo Fisher Scientific). The 340
cycling conditions were 50 C for 10 min and 95 C for 5 min, followed by 45 cycles of 95 C for 341 10 sec and 62 C for 30 sec. For all samples, the threshold cycle number (C t ) at which the 342 fluorescence values became logarithmic was determined. The ΔC t value was calculated for 343 each sample as the difference between the sample C t and the control C t . 344 345
Creation of icaADBC gene deletion using pKFT Vector 346
A JE2 double mazF::tn/ΔicaADBC strain was created from the base JE2 mazF::tn strain using 347 a previously described protocol (42). Briefly, the allelic replacement vector pFK74 containing 348 regions upstream 1.1kb and downstream 0.9 kb of the icaADBC gene was first transformed 349 into DNA restriction system-deficient S. aureus RN4220, then a modified plasmid was isolated 350
and electroporated into mazF::tn strain (NE1833) from NARSA NR-48501 library.
351
Transformants were selected at 30 °C on TSB plates containing tetracycline. A single colony 352
transformant was cultured at 30 °C in TSB media containing tetracycline in an orbital shaker.
353
Integration of the plasmid into the chromosome by a single crossover event was achieved by 354 incubation at 42 °C on TSB plates containing tetracycline. Correct homologous recombination 355 of the target region was verified by PCR using primer set of pUC-UV (5'-356
CGACGTTGTAAAACGACGGCCAGT-3', plasmid) and icaADBC 5'-up (5'-357
CCATCACATAGGCGCTTATCAA-3', chromosome) or pUC-RV (5'-358
CATGGTCATAGCTGTTTCCTGTG-3', plasmid) and icaADBC 3'-dn (5'-359
GAAGCAACGCACAAAGCATTA-3', chromosome). Integrants were grown at 25 °C overnight 360
with shaking in 10 ml TSB without any antibiotics. Bacteria was serially diluted and plated on 361 TSB plates at 42 °C. The excision of the plasmid region in the chromosome by a second 362 crossover event was screened for by isolation of tetracycline-sensitive colonies by replica-363 plating candidates on TSB plates versus TSB plates containing tetracycline (3 μg/ml).
364
Integrants were cultured overnight at 37 °C. Then, the markerless deletion mutants were 365 screened by PCR using primers icaADBC-1 (5'-AAAAAGATCTTTAGTAGCGAATACACTTC-366
3') and icaADBC-4 (5'-367 TACAAGATCTTTGGCATCATTTAGCAGAC-3') from tetracycline-sensitive colonies. The strain 368
with icaADBC deletion was screened by PCR and confirmed by DNA sequencing. 369 370
Cell growth curve and doubling time 371
Approximately 1x10 6 cells were added from overnight culture to fresh TSB medium and 372 incubated at 37°C. The OD 600 absorbance (TECAN, infinite M200) was measured every hour 373 during a 24 hour period. Calculation of the doubling time was based off of these 374 measurements. 375 376
Biofilm formation assay 377
Four titanium rods (12 mm) per well were incubated in TSB growth medium inoculated with 378 1x10 4 CFU S. aureus for 24 to 96 hours. Titanium rods were then washed three times with 1ml 379 PBS and then sonicated for 30 minutes in 1 ml fresh TSB medium. After serial 1:10 dilution, 380
the bacterial concentration (CFU/mL) was determined via colony-forming unit (CFU) assay on 381 TSA II blood agar plates (Thermo Fisher Scientific, USA). A semi-quantitative adherence 382 assay was performed on 96-well tissue culture polystyrene plates (Sigma-Aldrich, USA). Plates 383
were coated with 200 μl of phosphate-buffered saline (PBS) containing 5 μg/ml fibrinogen 384
(Sigma-Aldrich, USA) overnight at 4°C. Washed three times with PBS and then blocked with 385 100 μl of a 2% bovine serum albumin (BSA) solution for 1 h at 37°C. The wells were carefully 386 washed three times with 100 μl of PBS; 100 μl of bacteria (approximately 1x10 7 cells) was 387 added to the appropriate wells and incubated for 24 hours at 37 °C. The wells were washed 388 four times with 100 μl of PBS. Bacteria were fixed with 100 μl of 10 % formaldehyde (Sigma-389
Aldrich, USA) for 10 min. Then 100 μl of 0.2% crystal violet (Sigma-Aldrich, USA) was added 390
to each well for 10 min, cells were washed four times with distilled water. Air dried wells for 2 391 hours and then add 100 μl of 30% acetic acid (Fisher Scientific, USA) to dissolve crystal violet 392 and the absorbance was measured at 590 nm. 393 394
Minimum inhibitory concentration (MIC) assay 395
A single colony from an overnight agar plate was inoculated in 5 ml TSB medium to achieve 396 the specified inoculum turbidity by comparing to a 0.5x McFarland turbidity standard (~1x10 8 397 CFU/ml). A sterile swab was placed in the inoculum suspension and streaked across the entire 398 agar surface six times, rotating the plate to evenly distribute the inoculum. An Etest MIC test 399 strips (Liofilchem, Italy) was applied with sterile forceps. Agar plates were then incubated in an 400
inverted position at 37 °C overnight. 401 402
Biofilm and planktonic antibiotics tolerance assay 403
For biofilm assay, grow S. aureus strains on surgical implant material (12mm titanium rods) for 404 4 days to form mature biofilm (change medium every day). Then, exposed the mature biofilm 405
to 10x MIC of cefazolin or vancomycin for 3 days (change medium every day). Implants were 406 then washed, removed, sonicated, and plated to enumerate survivors (CFU assay) at each 407 day. For planktonic assay, grow S. aureus strains in fresh TSB media overnight. Next day, 408
1:100 diluted the overnight culture media with fresh TSB medium and grow to around 0.5X 409
McFarland turbidity under 37°C. Do CFU assay to determine the viable cells before the 410 treatment. Then, exposed the bacteria to 10X MIC cefazolin or vancomycin to Eight-week-old B57BL/6J mice were purchased from the Jackson laboratory (Bar Harbor, ME, 417 USA). All animal protocols used for these experiments were approved by the University of 418
Pittsburgh's Institutional Animal Care and Use Committee. Mice were rendered neutropenic by 419 two 100 µl intra peritoneal injections of cyclophosphamide (150 mg/kg three days pre-infection 420 and 100 mg/kg one day pre-infection). Mice where anesthetized by 2% isoflurane, hair was 421 removed from leg and treated with betadine. An inoculation volume of 100 µl, 1× 10 6 CFU of 422 JE2-WT or JE2-ΔmazF::tn strain was injected into the thigh. Mice were monitored for weight 423 loss, leg swelling, ambulatory abilities, signs of sepsis, and death. Mice were sacrificed at 1, 3, 424
and 7 days post infection. A ~5 x 5 mm piece of thigh muscle from infection site was obtained 425
and placed into 1% Tween 20 in PBS on ice. Abscess samples were sonicated 10 minutes, 426
and colony forming unit (CFU) assay was performed on blood agar plates to quantify bacterial 427 burden. 428 429
Statistical analysis 430
Statistical analysis was based on the number of populations and comparisons. Student t-test 431
was sued for two populations. One-way anova and two-way anova was used for comparing 432 multiple populations across either one condition or two conditions respectively. To determine 433 antibiotic tolerance, multilevel mixed-effects linear regression models were constructed to 434 compare the rate of change in CFU/mL over time between wild type and strains with loss of 435 mazF expression. The outcome, CFU/mL, was natural-log transformed to produce 436 approximately normally distributed values before fitting models via maximum likelihood 437 estimation (MLE). Bacteria type (WT, ΔmazF), time, and a type-by-time interaction were 438 included as fixed effects in the multilevel models, and the baseline concentration was 439 accounted for. Random effects for Experiment, as well as Group (nested within Experiment), 440
were included in all models to adjust for within-cluster correlation. Of primary interest were the 441 type-by-time interaction coefficients, which reflect the degree to which the rate of decline in 442 log-CFU differs between wildtype and ΔmazF bacteria. After fitting the models, the estimated 443
interaction Mature JE2 biofilm was cultured on surgical implant material (4 days on 12mm titanium rods), 586
and exposed to 10x MIC of vancomycin. Implants were then removed, sonicated, and plated to 587 enumerate survivors on a daily basis over 3 days. Remaining biofilm on surgical implant 588 material at each day was compared to the respective pretreated strain. All experiments were 589 completed in triplicate. ** p<0.01. Error bars represent 95% confidence intervals. tolerance in SH1000. The strain JE2 was not included in these experiments as it is methicillin 598
resistant. (C) Disruption of mazF expression decreased the planktonic vancomycin tolerance in 599 JE2 and SH1000 strains. All experiments were completed in triplicate. * p<0.05, ** p<0.01. 600
Error bars represent 95% CI (95% confidence interval). 601 602 Figure 4 . Loss of mazF expression had no effect on sigB expression 603 604
Quantitative real-time RT-PCR analysis of (A) sigB and (B) asp23 expression in three S. 605 aureus strains (JE2, Newman, and SH1000). ΔC t value were used to quantify gene expression 606 levels. No significant differences in sigB or asp23 expression were observed between the wild 607 type and loss of mazF expression in all three S. aureus strains. 
